Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: A potential method to differentiate malignancy from inflammation and normal tissue in the head and neck

European Journal of Nuclear Medicine

Volumn 26, Issue 10, 1999, Pages 1345-1348

  Hustinx, Roland ^a   Smith, Robin J ^a   Benard, Francois ^a   Rosenthal, David I ^b   Machtay, Mitchell ^b   Farber, Leonard A ^b   Alavi, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fluorine 18 fluorodeoxyglucose; Head and neck cancer; Inflammation; Positron emission tomography; Standardised uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEAD AND NECK CANCER; HUMAN; INFECTION; INFLAMMATORY DISEASE; LARYNX; MALE; MALIGNANT NEOPLASTIC DISEASE; POSITRON EMISSION TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; TIME; TONGUE;

DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032879180     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050593     Document Type: Article

References (10)

1. Rigo P, Paulus P, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 23: 1641-1674.
2. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996; 23: 1409-1415.
3. Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994; 35: 1308-1312.
4. Fischman AJ, Alpert NM. FDG-PET in oncology: there's more to it than looking at pictures. J Nucl Med 1993; 34: 6-11.
5. Karp J, Kinahan P, Muehllehnaer G. Effect of increased axial field of view on the performance of a volume PET scanner. IEEE Trans Med Imag 1993; 12: 299-306.
6. Smith R, Karp J, Muehllehner G, Gualtieri E, Benard F. Singles transmission scans performed post-injection for quantitative whole body PET imaging. IEEE Trans Nucl Sci 1997; 44: 1329-1335.
7. Meikle S, Hutton B, Bailey D, Hooper P, Fulham M. Accelerated EM reconstruction in total-body PET: potential for improving tumor detectability. Phys Med Biol 1994; 39: 1689-1709.
8. Smith R, Karp J, Bénard F, et al. A comparison of segmentation and emission subtraction for singles transmission in PET. IEEE Trans Nucl Sci 1998; 45: 1212-1217.
9. Paulus P, Sambon A, Vivegnis D, et al. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998; 108: 1578-1583.
10. Lodge MA, Lucas JD, Marsden PK, et al. A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med 1999; 26: 22-30.